Inactive Instrument

Medivation Inc Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

28/16/28	Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat	RE
08/16/08	Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources	RE

28/16/28	Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat	RE
08/16/08	Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources	RE
08/16/08	Abbott Laboratories : Medtech's 2016 stock surge confronts second-quarter test	RE
04/16/04	Medivation : Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips	RE
02/16/02	Medivation : sets eligibility date for shareholder consent on board revamp	RE
26/16/26	Lonza : Sanofi moves to oust Medivation board in $9.3 billion takeover fight	RE
26/16/26	Lonza : Sanofi moves to oust Medivation board in $9.3 billion takeover fight	RE
25/16/25	Exclusive: Sanofi to unveil challenge to Medivation's board - sources	RE
10/16/10	Astellas Pharma : Medivation succumbs to pressure to explore sale - sources	RE
09/16/09	Exclusive - Medivation succumbs to pressure to explore sale: sources	RE
06/16/06	Medivation : Sanofi ready to up offer for drugmaker Medivation, could oust board	RE
04/16/04	Medivation : Sanofi sees 'strong strategic' fit with U.S. Medivation	RE
04/16/04	Exclusive: Pfizer approaches Medivation about potential takeover - sources	RE

09/16/09	Medivation : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼ (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo	BU
09/16/09	Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit Against Medivation, Inc.	PR
26/16/26	Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	BU
26/16/26	Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of Medivation, Inc. for $81.50 Per Share is Fair to Shareholders	BU
24/16/24	SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Medivation, Inc. -MDVN	PR

28/16/28	Sanofi : relève ses prévisions pour 2016 et s'envole en Bourse
28/16/28	Sanofi : relève ses prévisions pour 2016 et veut céder ses activités génériques en Europe
10/16/10	Medivation : Neue, im Rahmen der ESMO 2016 präsentierte Ergebnisse belegen zusätzlich, dass XTANDITM▼ (Enzalutamid) die Zeit bis zur PSA-Progression bei fortgeschrittenem Prostatakarzinom im Vergleich zu Placebo signifikant verlängert
10/16/10	Medivation : De nouvelles données présentées au Congrès 2016 de l’ESMO démontrent une fois de plus que XTANDITM▼ (enzalutamide) améliore nettement, par rapport au placebo, le délai avant progression du PSA en cas de cancer de la prostate avancé
19/16/19	Sanofi : poursuit Merck en justice aux USA pour protéger les brevets de Lantus

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-0.38%	-2.64%	+42.69%	+99.03%	6.8TCr
ARGENX SE	-2.71%	-0.71%	+35.89%	+81.43%	6.49TCr
INSMED INCORPORATED	-0.31%	+3.67%	-12.96%	+374.95%	2.76TCr
BIONTECH SE	+0.86%	+2.12%	-7.74%	-13.34%	2.61TCr
WUXI BIOLOGICS (CAYMAN) INC.	-1.42%	-0.74%	+31.24%	+15.84%	2.57TCr
GENMAB A/S	-1.11%	+0.90%	+22.24%	-18.50%	2.01TCr
PHARMAESSENTIA CORPORATION	+1.15%	-5.02%	+219.82%	+379.02%	1.72TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.20%	-1.37%	-6.41%	+549.54%	1.49TCr
EXELIXIS, INC.	-0.20%	+8.00%	+55.78%	+167.98%	1.46TCr
Average	-0.44%	+0.99%	+42.28%	+181.77%	3.1TCr
Weighted average by Cap.	-0.81%	+0.47%	+37.32%	+140.48%